Helius Medical Technologies is trading 10.66% up at $3.05 amid a broader risk-on backdrop, while no clear company-specific announcement dated September 21 was identified in available coverage.

  • It closed at $2.76 on September 18, 2026, following a 20.52% regular-session gain.
  • The S&P 500 was up 0.64% and Nasdaq Composite up 0.92% in pre-market trading.
  • The stock’s larger move remains only partially explained.